Enhances the company's experience in producing lipids, one of the critical components for the formulation of mRNA therapeutics including Covid-19 vaccines.
Creates Guy Ourisson Research Campus boosting research capacity with plans to set up therapeutic innovation campus and center for cryo-electron microscopy.
Included manufacturing facility, equipment, labs, quality management system, tablet production, material handling, computer control systems, and data integrity.